Bausch Health Companies (BHC) Goodwill & Intangibles (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Goodwill & Intangibles came in at $14.2 billion in Q1 2026, down 13.61% year-on-year from $16.4 billion in Q1 2025, and down 10.7% quarter-over-quarter from $15.9 billion in Q4 2025.
Bausch Health Companies (BHC) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $14.2 billion for Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $14.2 billion, down 13.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.2 billion (down 13.61% YoY), and the FY2025 annual result was $15.9 billion, down 4.35% from the prior year.
- Goodwill & Intangibles came in at $14.2 billion for Q1 2026 at Bausch Health Companies, down from $15.9 billion in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $19.1 billion in Q1 2022 to a low of $6.5 billion in Q3 2022.
- The 5-year median for Goodwill & Intangibles is $16.8 billion (2024), against an average of $15.8 billion.
- Across the five-year window, Goodwill & Intangibles sank 67.04% in 2022 and jumped 112.41% in 2024, its largest moves.
- Bausch Health Companies' Goodwill & Intangibles stood at $17.3 billion in 2022, then advanced by 1.68% to $17.6 billion in 2023, then dropped by 5.67% to $16.6 billion in 2024, then slipped by 4.35% to $15.9 billion in 2025, then retreated by 10.7% to $14.2 billion in 2026.
- The last three Goodwill & Intangibles figures came in at $14.2 billion (Q1 2026), $15.9 billion (Q4 2025), and $16.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.21 Bn |
| Dec 31, 2025 | 15.91 Bn |
| Sep 30, 2025 | 16.12 Bn |
| Jun 30, 2025 | 16.35 Bn |
| Mar 31, 2025 | 16.45 Bn |
| Dec 31, 2024 | 16.64 Bn |
| Sep 30, 2024 | 16.82 Bn |
| Jun 30, 2024 | 17.03 Bn |
| Mar 31, 2024 | 17.34 Bn |
| Dec 31, 2023 | 17.64 Bn |
| Sep 30, 2023 | 7.92 Bn |
| Jun 30, 2023 | 16.93 Bn |
| Mar 31, 2023 | 17.13 Bn |
| Dec 31, 2022 | 17.35 Bn |
| Sep 30, 2022 | 6.50 Bn |
| Jun 30, 2022 | 18.59 Bn |
| Mar 31, 2022 | 19.06 Bn |
| Dec 31, 2021 | 19.41 Bn |
| Sep 30, 2021 | 19.74 Bn |
| Jun 30, 2021 | 20.15 Bn |